Search Within

David H Ilson

Formats
  1. Journal Article (210)
  2. Meeting Abstract (169)
  3. Book Section (20)
  4. Review (14)
  5. Editorial (9)
  6. Conference Paper (6)
  7. Guidelines (3)
  8. Correspondence (2)
  9. Book Whole (1)
  10. Miscellaneous (1)
  11. Research Letter (1)
Groups
  1. Department of Medicine (436)
  2. Gastrointestinal Oncology Service (436)
  3. Solid Tumor Oncology Division (436)
  4. Center for Pancreatic Cancer Research (187)
  5. Surgery (137)
  6. Survivorship Research (127)

More Groups

People
  1. David Kelsen (132)
  2. Geoffrey Ku (123)
  3. Yelena Janjigian (112)
  4. Marinela Capanu (65)
  5. Laura Tang (60)
  6. Manjit Bains (51)

More People

Years
  1. 2025 (8)
  2. 2024 (16)
  3. 2023 (24)
  4. 2022 (21)
  5. 2021 (22)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (135)
  2. Annals of Oncology (28)
  3. International Journal of Radiation Oncology, Biology, Physics (15)
  4. Journal of the National Comprehensive Cancer Network (14)
  5. Annals of Surgical Oncology (13)
  6. Cancer (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (137)
  2. Elsevier Inc. (59)
  3. Oxford University Press (41)
  4. Springer (32)
  5. Lippincott Williams & Wilkins (22)
  6. Wiley Blackwell (19)

More Publishers

Results (436)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Total neoadjuvant chemo (ctx; TNT) for locally advanced gastric cancer (GC): The Memorial Sloan Kettering Cancer Center experience
    Meeting Abstract

    Greally, M.; Strong, V. E.; Yoon, S. S.; Coit, D. G.; Chou, J. F.; Capanu, M.; Kelsen, D. P.; Janjigian, Y. Y.; Ilson, D. H.; Ku, G. Y.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical and molecular factors predicting resistance to first-line (1L) FOLFOX in patients (pts) with advanced esophagogastric cancer (EGA) and patterns of subsequent therapy
    Meeting Abstract

    Greally, M.; Walch, H. S.; Chou, J. F.; Capanu, M.; Kelsen, D. P.; Ilson, D. H.; Janjigian, Y. Y.; Schultz, N.; Ku, G. Y.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Analysis of symptoms and functional HRQoL scales in TAGS, a phase III trial of trifluridine/tipiracil (FTD/TPI) in metastatic gastric cancer (mGC)
    Meeting Abstract

    Alsina, M.; Tabernero, J.; Shitara, K.; Doi, T.; Dvorkin, M.; Mansoor, W.; Arkenau, H. T.; Prokharau, A.; Ghidini, M.; Faustino, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastric cancer (mGC) with or without prior gastrectomy: Results from a phase III study (TAGS)
    Meeting Abstract

    Ilson, D. H.; Prokharau, A.; Arkenau, H. T.; Ghidini, M.; Fujitani, K.; Van Cutsem, E.; Thuss-Patience, P. C.; Beretta, G. D.; Mansoor, W.; Zhavrid, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)
    Meeting Abstract

    Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Systemic chemo (CTX) plus surgery and intraperitoneal (IP) CTX for patients (pts) with gastric cancer (GC) and peritoneal carcinomatosis (PC)
    Meeting Abstract

    Greally, M.; Strong, V. E.; Yoon, S. S.; Chou, J. F.; Capanu, M.; Kelsen, D. P.; Janjigian, Y. Y.; Ilson, D. H.; Ku, G. Y.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I/Ib study of crenolanib with ramucirumab (RAM)/paclitaxel (PTX) as second -line therapy (2L tx) for advanced esophagogastric adenocarcinoma (EGA)
    Meeting Abstract

    Greally, M.; Jha, S.; Yoon, S. S.; Li, J.; Desai, A. M.; Won, E.; Kelsen, D. P.; Ilson, D. H.; Janjigian, Y. Y.; Aljallad, K.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Advances in the treatment of gastric cancer: 2019
    Review

    Ilson, D. H.
    Current Opinion in Gastroenterology (2019)

    Fulltext@MSK | Save
  • Clinical and molecular predictors of response to immune checkpoint inhibitors in patients with advanced esophagogastric cancer
    Journal Article

    Greally, M.; Chou, J. F.; Chatila, W. K.; Margolis, M.; Capanu, M.; Hechtman, J. F.; Tuvy, Y.; Kundra, R.; Daian, F.; Ladanyi, M.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save